As of 2024-12-12, the EV/EBITDA ratio of Albireo Pharma Inc (ALBO) is -5.66. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALBO's latest enterprise value is 693.41 mil USD. ALBO's TTM EBITDA according to its financial statements is -122.48 mil USD. Dividing these 2 quantities gives us the above ALBO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.1x - 16.5x | 15.0x |
| Forward P/E multiples | 15.0x - 17.7x | 15.8x |
| Fair Price | (78.08) - (86.46) | (79.91) |
| Upside | -276.8% - -295.8% | -281.0% |
| Date | EV/EBITDA |